SCHEMBL21451763

SCHEMBL21451763

CNCC[C@@H]1OCCc2c(Cl)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.41
L3MBTL4 Q8NA19 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DRD1 P21728 3/20 0.38
HTR2A P28223 1/20 0.38
HRH1 P35367 1/20 0.38
TAAR1 Q96RJ0 6/20 0.38
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
HTR7 P34969 1/20 0.34
PRMT5 O14744 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30360729 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL19813015 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL30360691 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL19812923 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL30360721 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL19812921 0.87 TAAR1 (0.51) HTR2CDRD1TAAR1SLC6A2SLC6A4
SCHEMBL21451736 0.84 DRD1 (0.39) L3MBTL4L3MBTL1DRD1HTR2AHRH1
SCHEMBL15319616 0.82 DRD1 (0.42) HTR2CDRD1HTR2ATAAR1ADRA2A
SCHEMBL19824791 0.81 OPRL1 (0.39) L3MBTL4L3MBTL1DRD1HTR2AHRH1
SCHEMBL22446808 0.81 HTR2A (0.39) HTR2CL3MBTL4L3MBTL1DRD1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927124-B2 Compounds and compositions and uses thereof SUNOVION PHARMACEUTICALS INC. (US) 2021-02-23 US disclosed
US-20190308990-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUNOVION PHARMACEUTICALS INC. 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927124-B2 Compounds and compositions and uses thereof CHAT, ACHE, MAOB HTR2C 190/4885L3MBTL4 4502/4885L3MBTL1 4456/4885
US-20190308990-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF CHAT, ACHE, MAOB HTR2C 190/4885L3MBTL4 4502/4885L3MBTL1 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.